Geode Capital Management, LLC Galectin Therapeutics Inc Transaction History
Geode Capital Management, LLC
- $1.24 Trillion
- Q1 2025
A detailed history of Geode Capital Management, LLC transactions in Galectin Therapeutics Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 852,706 shares of GALT stock, worth $1.78 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
852,706
Previous 870,589
2.05%
Holding current value
$1.78 Million
Previous $1.04 Million
0.39%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding GALT
# of Institutions
103Shares Held
10.1MCall Options Held
587KPut Options Held
2.02M-
Vanguard Group Inc Valley Forge, PA2.19MShares$4.58 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.56MShares$3.27 Million0.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ1.22MShares$2.56 Million0.0% of portfolio
-
Geneos Wealth Management Inc.423KShares$884,5610.02% of portfolio
-
Wealthspire Advisors, LLC New York, NY398KShares$832,6010.0% of portfolio
About GALECTIN THERAPEUTICS INC
- Ticker GALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,426,000
- Market Cap $124M
- Description
- Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...